TScan Therapeutics, Inc. (TCRX)
1.01
-0.02
(-1.94%)
USD |
NASDAQ |
Apr 02, 16:00
1.015
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Profit Margin (Quarterly) : -895.1% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Lexicon Pharmaceuticals, Inc. | -282.7% |
| Agios Pharmaceuticals, Inc. | -541.1% |
| Sutro Biopharma, Inc. | -401.5% |
| Recursion Pharmaceuticals, Inc. | -304.2% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.49% |
| Return on Assets | -43.45% |
| Return on Invested Capital | -47.16% |
| Gross Profit Margin (Quarterly) | 71.83% |
| Operating Margin (Quarterly) | -929.4% |
| Return on Net Operating Assets | -186.2% |